Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory Peripheral T-Cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03107962
What this trial is testing

Treatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Mingzhi Zhang 20
Early research (Phase 1)Study completedNCT00003962
What this trial is testing

Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Early research (Phase 1)Not Yet RecruitingNCT07842445
What this trial is testing

Phase 1a/1b Clinical Trials to Evaluate the Safety and Preliminary Efficacy of GNTbm-38.

Who this might be right for
Solid Tumor (Phase I)Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL)
Great Novel Therapeutics Biotech & Medicals Corporation 70
Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Very early researchLooking for participantsNCT07598578
What this trial is testing

An Open-label, Single-arm, Multicenter Phase II Clinical Study of Azacitidine, Chidamide Combined With PD-1 Monoclonal Antibody in the Treatment of Refractory/Relapsed Peripheral T-cell Lymphoma.

Who this might be right for
Peripheral T-Cell Lymphoma Refractory
Second Affiliated Hospital of Soochow University 30
Testing effectiveness (Phase 2)UnknownNCT04917250
What this trial is testing

GPED for Patients With Relapsed/Refractory or Advanced NK/T-cell Lymphoma

Who this might be right for
Extranodal NK/T-cell Lymphoma
Beijing Tongren Hospital 15
Testing effectiveness (Phase 2)Looking for participantsNCT06733051
What this trial is testing

Phase II Study of Golidocitinib and Benmelstobart in Patients with R/R ENKTL (JACKPOT50)

Who this might be right for
Natural Killer T-cell Lymphoma
Sun Yat-sen University 47
Testing effectiveness (Phase 2)UnknownNCT05941156
What this trial is testing

Clinical Study of Anti-CD56-CAR-T in the Treatment of Relapsed/Refractory NK/T Cell Lymphoma /NK Cell Leukemia

Who this might be right for
Extranodal NK T Cell LymphomaNK-Cell Leukemia
The Affiliated Hospital of Xuzhou Medical University 20
Early research (Phase 1)Temporarily pausedNCT04828174
What this trial is testing

Anti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell Malignancies

Who this might be right for
Peripheral T Cell LymphomaAngioimmunoblastic T-cell LymphomaAnaplastic Lymphoma+2 more
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 9
Testing effectiveness (Phase 2)UnknownNCT04705090
What this trial is testing

YY-20394 in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma

Who this might be right for
PTCL
Shanghai YingLi Pharmaceutical Co. Ltd. 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07791615
What this trial is testing

A Phase II Study of Stapokibart Combined With Immune Checkpoint Inhibitors in Relapsed/Refractory Lymphoma

Who this might be right for
LymphomaNK T-Cell Lymphoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 20
Testing effectiveness (Phase 2)UnknownNCT05179213
What this trial is testing

Azacytidine Plus Chidamide in the Treatment of Relapsed and Refractory Angioimmunoblastic T-cell Lymphoma

Who this might be right for
Angioimmunoblastic T-cell Lymphoma
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06966154
What this trial is testing

A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL

Who this might be right for
Natural Killer/T-cell LymphomaRelapsed or Refractory Lymphoma Including ENKL
Fudan University 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07139353
What this trial is testing

Linperlisib Combined With Chidamide in the Treatment of Relapsed or Refractory Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T Cells Lymphoma (PTCL)
Sun Yat-sen University 54
Not applicableEnded earlyNCT00813501
What this trial is testing

Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+7 more
City of Hope Medical Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT05833724
What this trial is testing

Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)

Who this might be right for
Relapsed or Refractory Peripheral T-cell Lymphoma
Great Novel Therapeutics Biotech & Medicals Corporation 33
Large-scale testing (Phase 3)Study completedNCT00008359
What this trial is testing

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT02168140
What this trial is testing

CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

Who this might be right for
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin Lymphoma+14 more
Wake Forest University Health Sciences 16
Early research (Phase 1)Study completedNCT03905135
What this trial is testing

Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies

Who this might be right for
Peripheral T-cell Lymphoma NOSMycosis FungoidesSezary Syndrome+1 more
National Cancer Institute (NCI) 8
Early research (Phase 1)Ended earlyNCT02978235
What this trial is testing

A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma

Who this might be right for
Multiple MyelomaNonHodgkin Lymphoma
Taiho Oncology, Inc. 11
Next Page